High levels of HE4 expression have been found in NSCLC, and most studies focus on the biomarker roles of HE4 in lung cancer diagnosis [19,20,28], involving differences such as gender, race, and tumor progressive stage in NSCLC and SCLC. Here, WFDC2 is linked to non-small cell lung carcinoma.